Echo Therapeutics (ECTE) Reports Q1 Loss of $0.23/Share

Echo Therapeutics (NASDAQ: ECTE) reported Q1 EPS of ($0.23), versus ($0.72) reported last year.

For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Activist investors push Seer, Inc. to disclose go-private timeline